ALLOVIR INC's ticker is ALVR and the CUSIP is 019818103. A total of 62 filers reported holding ALLOVIR INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,481,732 | -36.5% | 1,154,294 | +0.5% | 0.02% | -33.3% |
| Q2 2023 | $3,906,804 | -13.3% | 1,149,060 | +0.5% | 0.02% | -20.0% |
| Q1 2023 | $4,506,884 | -23.2% | 1,143,879 | +0.0% | 0.03% | -26.8% |
| Q4 2022 | $5,866,565 | -35.0% | 1,143,580 | -0.0% | 0.04% | -37.9% |
| Q3 2022 | $9,023,000 | +102.3% | 1,143,634 | +0.0% | 0.07% | +120.0% |
| Q2 2022 | $4,460,000 | -42.2% | 1,143,425 | -0.0% | 0.03% | -28.6% |
| Q1 2022 | $7,719,000 | -47.9% | 1,143,532 | -0.1% | 0.04% | -43.2% |
| Q4 2021 | $14,810,000 | -48.4% | 1,144,562 | -0.0% | 0.07% | -51.6% |
| Q3 2021 | $28,695,000 | +44.6% | 1,145,032 | +13.9% | 0.15% | +128.4% |
| Q2 2021 | $19,847,000 | -15.7% | 1,005,415 | -0.1% | 0.07% | -19.3% |
| Q1 2021 | $23,544,000 | -32.7% | 1,006,142 | +10.5% | 0.08% | -36.2% |
| Q4 2020 | $34,997,000 | +11763.4% | 910,419 | +8394.3% | 0.13% | +12900.0% |
| Q3 2020 | $295,000 | – | 10,718 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 5,577,167 | $44,004,000 | 1.88% |
| GMT CAPITAL CORP | 2,758,846 | $21,767,000 | 1.35% |
| Regency Capital Management Inc.\DE | 75,010 | $592,000 | 0.73% |
| Redmile Group, LLC | 1,907,969 | $15,054,000 | 0.58% |
| Samsara BioCapital, LLC | 82,336 | $650,000 | 0.15% |
| Alkeon Capital Management | 4,923,104 | $38,843,000 | 0.13% |
| Woodline Partners LP | 1,087,093 | $8,577,000 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 77,625 | $612,000 | 0.08% |
| CORNERCAP INVESTMENT COUNSEL INC | 44,987 | $355,000 | 0.07% |
| AMERICAN INTERNATIONAL GROUP, INC. | 1,143,634 | $9,023,000 | 0.07% |